- Inicio
- Por qué U.Mayor
- Director
PhD en ciencias Biológicas en la Universidad Catolica de Chile. Posteriormente se traslado al MD Anderson Cancer Center, USA donde desarrollo su postdoctorado estudiando mecanismos moleculares de resistencia a la terapias antitumorales.
Trayectoria
Present Title and Affiliation
Assistant Professor, Center for Integrative Biology, Universidad Mayor, Camino La Piramide 5750
Huechuraba 8580745, Santiago, Chile
Positions and Employment
2001-2005 Medical Technology, Pontificia Universidad Católica de Chile. I was responsible for molecular diagnostic and research in human tumor samples
2005-2010 Postdoctoral Fellow Research Biomedical Research Consortium, Pontificia Universidad Católica de Chile. I was responsible for investigating molecular characterization of chemokines in thyroid cancer
2010-2016 Postdoctoral Fellow, UT MD Anderson Cancer Center, Houston, TX. Molecular mechanisms associated with resistance to therapy in non-small cell lung cancer (NSCLC)
2016-2019 Research Scientific, Department of Clinical Cancer Prevention, UT MD Anderson Cancer Center
March 2019-Present Assistant Professor, Center for Integrative Biology, Universidad Mayor
Education
Degree-Granting Education
2001 Medical Technology Degree, University of Chile, Santiago, Chile
2007 Master in Biological Science, Pontificia Universidad Católica de Chile, Santiago, Chile
2009 Ph.D., Biological Science, Molecular Genetic and Microbiology. Pontificia Universidad Católica de Chile, Santiago, Chile
Postgraduate Training
2009-2010 Postdoctoral Fellow, UT MD Anderson Cancer Center, Houston, TX. Molecular mechanisms associated with resistance to therapy in non-small cell lung cancer (NSCLC)
Memberships
2010-Present American Association for Cancer Research, AACR
Honors
2005-2009 CONICYT Doctoral Fellowship, Santiago, Chile
2011-2012 Becas Chile Post-Doctoral Fellowship, Santiago, Chile
Project
FONDECYT Regular, 1191526
Publicaciones
-
Tumor Microbiome Diversity and Composition influence Pancreatic Cancer Outcomes. Cell. 2019 Aug 8;178(4):795-806. |
-
Immune Profiling of Premalignant Lesions in Patients With Lynch Syndrome JAMA Oncol. 2018 Apr 16 | PDF
-
Immunotherapy for Pancreatic Cancer: More Than Just a Gut Feeling Cancer Discov. 2018 Apr;8(4):386-388 | PDF
-
Immunological regulation of stemness in pancreatic progenitor cells Gastroenterology. 2018 Jul; 155(1):210-223. | PDF
-
Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients Science. 2017 Nov 2 | PDF